Call-On-Doc Review
Semaglutide GLP-1 weight-loss telehealth · Independently scored 5.7/10
Best for: coverage in all 50 states, which most sellers will not confirm
Call-On-Doc falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the plan
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
Call-On-Doc runs a GLP-1 weight-loss program inside a broad multi-condition telehealth service that by its own account has 2M+ patients and 800k+ five-star reviews. Visits are flat-rate with no appointment needed, and the site says most finish within two hours, seven days a week, text consults included. Branded Wegovy, Ozempic, Mounjaro, Zepbound and Saxenda can be prescribed by board-certified providers across all 50 states plus DC. Insurance can be used at the pharmacy and an Rx savings card is offered.
Is Call-On-Doc legit?
Yes. Call-On-Doc is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 5.7/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Call-On-Doc promo or coupon code?
We know of no promo or coupon code for Call-On-Doc. Coupon sites advertising "Call-On-Doc discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Call-On-Doc compares on our rankings of the best semaglutide providers.
Vetted alternatives to Call-On-Doc
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Call-On-Doc at a glance
- Type
- GLP-1 telehealth provider
- What's included
- Consult
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Call-On-Doc scores
Six columns, each one computed from something Call-On-Doc has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10The listed figure is not a comparable monthly price for a named GLP-1 (it may be a membership fee, an insured copay, a per-vial rate or a starting-dose price), so Value is capped rather than scored against other sellers.
Effectiveness25%
9.0/10Dispenses semaglutide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves 50 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Call-On-Doc
Last checked August 2026- Checked the listed price across 1 dose or plan tier
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Call-On-Doc
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Call-On-Doc involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Call-On-Doc shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Call-On-Doc which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes clinician visits.
- Before you commit, get the ongoing monthly price of the medication itself, not a first-month rate, a membership fee or a per-vial price.
- Call-On-Doc serves all 50 states.
Contacting Call-On-Doc
- Phone
- +1 (214) 466-6618
- Hours
- 24/7 customer support; live call daily 5am CT - 3am CT
GLP-1 medications Call-On-Doc offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off Call-On-Doc's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price includes clinician visits
- Serves all 50 states
- We found no FDA warning letters issued to Call-On-Doc
Against it
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What Call-On-Doc charges
There is no standard monthly price to quote for Call-On-Doc, so you cannot compare it with other sellers until you have been through an intake and received a quote. When you get one, ask for the ongoing monthly figure and what it includes, not the first-month rate and not a program total divided by its length.
What Call-On-Doc dispenses
Call-On-Doc prescribes semaglutide (approved as Wegovy and Ozempic). That is one of the most heavily studied molecules in this class. These are FDA-approved brand-name products rather than compounded preparations, which is the more expensive route and the one where what is in the pen has been reviewed.
Safety and disclosure
Call-On-Doc tells you that it treats patients in all 50 states. It also offers clinician messaging between visits. We found no FDA warning letters issued to Call-On-Doc. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want to compare prices before spending time on an intake. There is no standard monthly price to compare.
It fits if
- you need access wherever you live
- reaching a clinician between visits matters to you
- you want to try routing the cost through your insurance
Our read
Whether Call-On-Doc is priced well is impossible to judge before an intake, because there is no standard price to compare. That does not rule it out, and plenty of legitimate sellers quote after intake, but it puts the comparison after you have spent the time, which is the wrong order for you as the buyer. Collective is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Call-On-Doc falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay Call-On-Doc
Check today's price, then start the intake.
Compare Call-On-Doc head to head
The sellers closest to Call-On-Doc on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Call-On-Doc review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
See Call-On-Doc's current pricing
Whether you qualify is a clinician's decision, made after your intake.